Is the declining use of long-term peritoneal dialysis justified by outcome data?

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 6, 2007, Pages 1317-1328

  Khawar, Osman ^a,b   Kalantar Zadeh, Kamyar ^a,b   Lo, Wai Kei ^c   Johnson, David ^d   Mehrotra, Rajnish ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TUNG WAH HOSPITAL   (Hong Kong)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; ECONOMICS; HEALTH CARE COST; HUMAN; MORTALITY; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; RENAL DIALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 38449099186     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02550607     Document Type: Review

References (94)

1. Grassmann A, Gioberge S, Moeller S, Brown G: ESRD patients in 2004: Global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 20: 2587-2593, 2005
2. US Renal Data System: Annual data report. Bethesda, US Department of Health and Human Services, Public Health Service, National Institutes of Health, 2006
3. Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, Collins AJ: Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 16: 3736-3741, 2005
4. Cass A, Chadban S, Craig J, Howard H, McDonald S, Salkeld G, White S: The Economic Impact of End-Stage Kidney Disease in Australia, Melbourne, Kidney Health Australia, 2006
5. Popovich RP, Moncrief JW, Dechert JF, Pyle WK, Morris S, Lindley JD: The definition of a portable/wearable equilibrium dialysis technique [Abstract]. Trans Am Sac Artif Int Org 5: 64, 1976
6. Nolph KD, Sorkin M, Rubin J, Arfania D, Prowant B, Fruto L, Kennedy D: Continuous ambulatory peritoneal dialysis: Three-year experience at one center. Ann Intern Med 92: 609-613, 1980
7. Gutman RA, Blumenkrantz MJ, Chan YK, Barbour GL, Gandhi VC, Shen FH, Tucker T, Murawski BJ, Coburn JW, Curtis FK: Controlled comparison of hemodialysis and peritoneal dialysis: Veterans Administration multicenter study. Kidney Int 26: 459-470, 1984
8. Nissenson AR, Prichard SS, Cheng IK, Gokal R, Kubota M, Maiorca R, Riella MC, Rottembourg J, Stewart JH: Non-medical factors that impact on ESRD modality selection. Kidney Int Suppl 40: S120-S127, 1993
9. Van Biesen W, Wiedemann M, Lameire N: End-stage renal disease treatment: A European perspective. J Am Soc Nephrol 9[Suppl]: S55-S62, 1998
10. Viglino G, Neri L, Alloatti S, Cabiddu G, Cocchi R, Limido A, Marinangeli G, Russo R, Teatini U, Schena FP: Analysis of the factors conditioning the diffusion of peritoneal dialysis in Italy. Nephrol Dial Transplant June 30, 2007 [epub ahead of print]
11. Shih YC, Guo A, Just PM, Mujais S: Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int 68: 319-329, 2005
12. Mendelssohn DC: Empowerment of patient preference in dialysis modality selection. Am J Kidney Dis 43: 930-932, 2004
13. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR: Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 291: 697-703, 2004
14. Prichard SS: Treatment modality selection in 150 consecutive patients starting ESRD therapy. Perit Dial Int 16: 69-72, 1996
15. Little J, Irwin A, Marshall T, Rayner H, Smith S: Predicting a patient's choice of dialysis modality: Experience in a United Kingdom renal department. Am J Kidney Dis 37: 981-986, 2001
16. Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW: The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in the Netherlands. Am J Kidney Dis 43: 891-899, 2004
17. Mehrotra R, Marsh D, Vonesh E, Peters V, Nissenson A: Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int 68: 378-390, 2005
18. Mehrotra R: Peritoneal dialysis penetration in the United States: March toward the fringes? Pent Dial mt 26: 419-422, 2006
19. Mehrotra R, Blake P, Berman N, Nolph KD: An analysis of dialysis training in the United States and Canada. Am J Kidney Dis 40: 152-160, 2002
20. Thamer M, Hwang W, Fink NE, Sadler JH, Wills S, Levin N, Bass EB, Levey AS, Brookmeyer R, Powe NR: US nephrologists' recommendation of dialysis modality: Results of a national survey. Am J Kidney Dis 36: 1155-1165, 2000
21. Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR: Relation between pediatric experience and treatment recommendations for children and adolescents with kidney failure. JAMA 285: 1027-1033, 2001
22. Excerpts from United States Renal Data System 1997 Annual Data Report. Am J Kidney Dis 30: S1-S213, 1997 [published erratum appears in Am J Kidney Dis 30: 732, 1997]
23. O'Hare AM, Johansen KL, Rodriguez RA: Dialysis and kidney transplantation among patients living in rural areas of the United States. Kidney Int 69: 343-349, 2006
24. Mehrotra R, Kermah D, Fried L, Kalantar-Zadeh K, Khawar O, Norris K, Nissenson A: Chronic peritoneal dialysis in the United States: Improving outcomes but declining utilization. J Am Soc Nephrol 18: 2781-2788, 2007
25. Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, Krediet RT: Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trial. Kidney Int 64: 2222-2228, 2003
26. Maiorca R, Cancarini GC: Outcome with peritoneal dialysis compared to hemodialysis. In: Textbook of Peritoneal Dialysis, 2nd Ed., edited by Gokal R, Khanna R, Krediet RT, Nolph KD, Dordrecht, Kluwer Academic Publishers, 2000, pp 755-784
27. Bloembergen WE, Port FK, Mauger EA, Wolfe RA: A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephnol 6:177-183, 1995
28. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston F, Jeffery JR, Kjellstrand CM: Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 30: 334-342, 1997
29. Vonesh EF, Moran J: Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 10: 354-365, 1999
30. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA: Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 45:1163-1169, 1994
31. Murphy SW, Foley RN, Barrett BJ, Kent GM, Morgan J, Barré P, Campbell P, Fine A, Goldstein MB, Handa SP, Jindal KK, Levin A, Mandin H, Muirhead N, Richardson RM, Parfrey PS: Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int 57: 1720-1726, 2000
32. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, Ma JZ: Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 34: 1065-1074, 1999
33. Vonesh EF, Snyder JJ, Foley RN, Collins AJ: The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 66: 2389-2401, 2004
34. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, Levin NW, Sadler JH, Kliger A, Powe NR: Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 143: 174-183, 2005
35. Heaf JG, Lokkegaard H, Madsen M: Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 17: 112-117, 2002
36. Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, Krediet RT: Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis-Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 14: 2851-2860, 2003
37. Liem YS, Wong JB, Hunink MG, de Charro FT. Winkelmayer WC: Comparison of hemodialysis and peritoneal dialysis survival in the Netherlands. Kidney Int 71: 153-158, 2007
38. Piraino B, Bargman J: Does the risk of death differ between peritoneal dialysis and hemodialysis patients? Nat Clin Pract Nephrol 2: 128-129, 2006
39. Daly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD, Grant AM, Donaldson C, Wallace SA, Lawrence PD, Khan IH: Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 16: 341-347, 2001
40. Mehrotra R, Marwaha T, Berman N, Mason G, Appell M, Kopple JD: Reducing peritonitis rates in a peritoneal dialysis program of indigent ethnic minorities. Perit Dial Int 23: 83-85, 2003
41. Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, Movilli E, Pola A, d'Avolio G, Gelatti U: Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: A longitudinal study. Nephrol Dial Transplant 10: 2295-2305, 1995
42. Davies SJ, Phillips L, Russell GI: Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 13: 962-968, 1998
43. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SM, Zhu X, Lazarus TM: Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis 33: 523-534, 1999
44. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JG, Stevens P, Bos WJ, Krediet RT, NECOSAD Study Group: Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of the Netherlands Cooperative Study on the Adequacy of Dialysis. Kidney Int 55: 1476-1485, 1999
45. Szeto CC, Wong TY, Leung CB, Wang AY, Law MC, Lui SF, Li PK: importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 58: 400-407, 2000
46. Rocco M, Soucie JM, Pastan S, McClellan WM: Peritoneal dialysis adequacy and risk of death. Kidney Int 58: 446-457, 2000
47. Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol 12: 2158-2162, 2001
48. Shemin D, Bostom AG, Laliberty P, Dworkin LD: Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 38: 85-90, 2001
49. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15: 1061-1070, 2004
50. Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Cueffaf B, Legrain M: Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 19: 397-403, 1983
51. Cancarini CC, Brunori C, Camerini C, Brasa S, Manili L, Maiorca R: Renal function recovery and maintenance of residual diuresis in CAPD and hemodialysis. Perti Dial Bull 7: 77-79, 1986
52. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock CA, Prowant B, Farrell PC: The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 37: 598-604, 1991
53. Misra M, Vonesh E, Vanstone J, Moore HL, Prowant B, Nolph KD: Effect of cause and time of dropout on residual CFR: A comparative analysis of the decline of GFR on dialysis. Kidney Int 59: 754-763, 2001
54. Lang SM, Bergner A, Topfer M, Schiffl H: Preservation of residual renal function in dialysis patients: Effects of dialysis-technique-related factors. Pent Dial Int 21: 52-57, 2001
55. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62: 1046-1053, 2002
56. McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K: Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 61: 256-265, 2002
57. Centers for Medicare and Medicaid Services, Kinney R: 2005 Annual Report: End Stage Renal Disease Clinical Performance Measures Project. Am J Kidney Dis 48[Suppl 2]: S1-S106, 2006
58. Ishani A, Collins AJ, Herzog CA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 study. Kidney Int 68: 311-318, 2005
59. Aslam N, Bernardini J, Fried L, Burr R, Piraino B: Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol 1:1226-1233, 2006
60. Plum J, Schoenicke G, Kleophas W, Kulas W, Steffens F, Azem A, Grabensee B: Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transplant 16: 2378-2385, 2001
61. Konings CJ, Kooman JP, Schonck M, Struijk DC, Gladziwa U, Hoorntje SJ, van der Wall Bake AW, van der Sande FM, Leunissen KM: Fluid status in CAPD patients is related to peritoneal transport and residual renal function: Evidence from a longitudinal study. Nephrol Dial Transplant 18: 797-803, 2003
62. Davies SJ: Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 66: 2437-2445, 2004
63. Ates K, Nergizoglu C, Keven K, Sen A, Kutlay S, Erturk S, Duman N, Karatan O, Ertug AE: Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 60: 767-776, 2001
64. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, Divino Filho JC, Vonesh F, van Bree M, on behalf of the EAPOS Group: Survival of functionally anuric patients on automated peritoneal dialysis: The European APD Outcome Study. J Am Soc Nephrol 14: 2948-2957, 2003
65. Jansen MA, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten E, Krediet RT: Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 68: 1199-1205, 2005
66. Johnson DW, Armstrong K, Campbell SB, Mudge DW, Hawley CM, Coombes JS, Pins JP, Isbel NM: Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 12: 391-398, 2007
67. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J: The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 66: 408-418, 2004
68. Lee HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, Kim YH, Kim YL, Kim DJ, Kim YS, Ahn C, Kim MJ, Shin SK: Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int 25: 248-255, 2005
69. Brown F, Johnson DW: A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients. Perit Dial Int 26: 112-113, author reply 114, 2006
70. Kalantar-Zadeh K, Block C, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63: 793-808, 2003
71. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MI: Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition. JAMA 291: 451-459, 2004
72. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf C, Ritz F: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005
73. Cice C, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabro R: Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial. J Am Coll Cardiol 41: 1438-1444, 2003
74. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD. Horwich TB: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81: 543-554, 2005
75. Abbott KC, Oliver DK, Hurst FP, Das NP, Gao SW, Perkins RP: Body mass index and peritoneal dialysis: "Exceptions to the exception" in reverse epidemiology? Semin Dial 2007, in press
76. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis: Report of the Diaphane collaborative study. Nephron 31: 103-110, 1982
77. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ: Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 31: 997-1006, 1998
78. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK: Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55: 1560-1567, 1999
79. Kopple JD, Zhu X, Lew NL, Lowrie EG: Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 56: 1136-1148, 1999
80. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK: Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 35: 80-88, 2000
81. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW: Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 16: 2386-2394, 2001
82. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13: 1061-1066, 2002
83. Lowrie EG, Li Z, Ofsthun N, Lazarus JM: Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 62: 1891-1897, 2002
84. Glanton CW, Hypolite IO, Hshieh PB, Agodoa LY, Yuan CM, Abbott KC: Factors associated with improved short term survival in obese end stage renal disease patients. Ann Epidemiol 13: 136-143, 2003
85. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, Cruess DF, Kimmel PL: Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 65: 597-605, 2004
86. Stack AG, Murthy BV, Molony DA: Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Kidney Int 65: 2398-2408, 2004
87. Johansen KL, Young B, Kaysen GA, Chertow GM: Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 80: 324-332, 2004
88. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S: Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46: 489-500, 2005
89. Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby RJ, Campbell SB, Nicol DL, Hawley CM: Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int 20: 715-721, 2000
90. Aslam N, Bernardini J, Fried L, Piraino B: Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int 22: 191-196, 2002
91. McDonald SP, Collins JF, Johnson DW: Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 14: 2894-2901, 2003
92. Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ: Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 64: 1838-1844, 2003
93. Li P, Chow KM, Wong TY, Leung CB, Szeto CC: Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis: A randomized, controlled study. Ann Intern Med 139: 105-112, 2003
94. Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H: Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis 43: 1056-1064, 2004